Imagen de perfil
$NOVO B I wouldn't have bought it now.
11
Imagen de perfil
Yes, I wanted something for healthcare, maybe the iShares MSCI World Health Care would have been better after all. Let's see, if Novo doesn't perform, I'll just have to switch again... Why not? What would you have bought in the healthcare sector?
1
Imagen de perfil
@M3nt4list That depends on how much risk and volatility you can tolerate. And for how long?
Imagen de perfil
@Multibagger
My horizon is 20+ years (retirement provision/long-term portfolio). I can ride out fluctuations (drawdowns) of 30-40% as long as the investment case remains fundamentally intact.
1
Imagen de perfil
@M3nt4list then take a look at $BNTX.
Imagen de perfil
Well, it won't be quite that bad: Novo Nordisk is, after all, the world market leader in insulin - so it's a very big hobbyhorse to ride... In my opinion, it's too short-sighted that everyone is only thinking about weight loss. In the insulin sector we have things like Novorapid, FIASP, Levemir, which pretty much every diabetic should know.
2
Imagen de perfil
@Saarmupfel But the fantasy of above-average profits is in the slimming products. The other area has no potential for surprises.
1
Imagen de perfil
@Multibagger Thanks for the idea! I'll put Biontech on my watchlist. Thanks to the high cash position, the downside risk is well cushioned, so it's more of a bet with a safety net. Nevertheless, the hurdle in cancer research remains high and success will not be a foregone conclusion. Good luck with it! 🤞
Imagen de perfil
@Multibagger probably true, but at least it creates the feeling of investing in a solid company...
2
Imagen de perfil
@M3nt4list They have 16 candidates in the pipeline. The study results so far have been good and I think 2-3 with blockbuster potential will come through.
@Multibagger you are clearly too pessimistic for novo
2